The Global Alzheimer’s Platform Foundation (GAP) is a person centered non-profit organization dedicated to speeding the delivery of innovative therapies to those in need by reducing the time and cost of Alzheimer’s disease and other neurodegenerative disorder’s clinical trials.
In 2017, GAP-Net was established by GAP, a growing network of more than 75 Alzheimer’s disease (AD) and Parkinson’s Disease (PD) research centers committed to disrupting recruitment and study conduct processes to increase the speed and lower the cost of completing clinical trials. GAP supports GAP-Net research centers by assisting with study start up and recruitment activities, promoting inclusive research, and offering national programs that champion brain health and the citizen scientists who make research possible.